A citation-based method for searching scientific literature

K Duff, J Paulsen, J Mills, L J Beglinger, D J Moser, M M Smith, D Langbehn, J Stout, S Queller, D L Harrington. Neurology 2010
Times Cited: 100







List of co-cited articles
966 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
549
44

Neurocognitive signs in prodromal Huntington disease.
Julie C Stout, Jane S Paulsen, Sarah Queller, Andrea C Solomon, Kathryn B Whitlock, J Colin Campbell, Noelle Carlozzi, Kevin Duff, Leigh J Beglinger, Douglas R Langbehn,[...]. Neuropsychology 2011
253
41


Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
Sarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, Raymund Ac Roos, Alexandra Durr, David Craufurd, Christopher Kennard, Stephen L Hicks, Nick C Fox, Rachael I Scahill,[...]. Lancet Neurol 2009
652
27

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.
D R Langbehn, R R Brinkman, D Falush, J S Paulsen, M R Hayden. Clin Genet 2004
539
23

Preparing for preventive clinical trials: the Predict-HD study.
Jane S Paulsen, Michael Hayden, Julie C Stout, Douglas R Langbehn, Elizabeth Aylward, Christopher A Ross, Mark Guttman, Martha Nance, Karl Kieburtz, David Oakes,[...]. Arch Neurol 2006
235
22

Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.
Kevin Duff, Jane S Paulsen, Leigh J Beglinger, Douglas R Langbehn, Julie C Stout. Biol Psychiatry 2007
269
21

Clinical markers of early disease in persons near onset of Huntington's disease.
J S Paulsen, H Zhao, J C Stout, R R Brinkman, M Guttman, C A Ross, P Como, C Manning, M R Hayden, I Shoulson. Neurology 2001
159
18

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Sarah J Tabrizi, Rachael I Scahill, Alexandra Durr, Raymund Ac Roos, Blair R Leavitt, Rebecca Jones, G Bernhard Landwehrmeyer, Nick C Fox, Hans Johnson, Stephen L Hicks,[...]. Lancet Neurol 2011
390
17

Indexing disease progression at study entry with individuals at-risk for Huntington disease.
Ying Zhang, Jeffrey D Long, James A Mills, John H Warner, Wenjing Lu, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2011
148
17

Cognitive domains that predict time to diagnosis in prodromal Huntington disease.
Deborah Lynn Harrington, Megan M Smith, Ying Zhang, Noelle E Carlozzi, Jane S Paulsen. J Neurol Neurosurg Psychiatry 2012
66
25

Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study.
Kevin M Biglan, Christopher A Ross, Douglas R Langbehn, Elizabeth H Aylward, Julie C Stout, Sarah Queller, Noelle E Carlozzi, Kevin Duff, Leigh J Beglinger, Jane S Paulsen. Mov Disord 2009
107
16

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
933
16

CAG repeat number governs the development rate of pathology in Huntington's disease.
J B Penney, J P Vonsattel, M E MacDonald, J F Gusella, R H Myers. Ann Neurol 1997
486
16

Cognitive decline in prodromal Huntington Disease: implications for clinical trials.
Jane S Paulsen, Megan M Smith, Jeffrey D Long. J Neurol Neurosurg Psychiatry 2013
67
23

Earliest functional declines in Huntington disease.
Leigh J Beglinger, Justin J F O'Rourke, Chiachi Wang, Douglas R Langbehn, Kevin Duff, Jane S Paulsen. Psychiatry Res 2010
88
17


Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Sarah J Tabrizi, Rachael I Scahill, Gail Owen, Alexandra Durr, Blair R Leavitt, Raymund A Roos, Beth Borowsky, Bernhard Landwehrmeyer, Chris Frost, Hans Johnson,[...]. Lancet Neurol 2013
502
15

Evidence for specific cognitive deficits in preclinical Huntington's disease.
A D Lawrence, J R Hodges, A E Rosser, A Kershaw, C ffrench-Constant, D C Rubinsztein, T W Robbins, B J Sahakian. Brain 1998
306
14

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
14

Self-paced timing detects and tracks change in prodromal Huntington disease.
Kelly C Rowe, Jane S Paulsen, Douglas R Langbehn, Kevin Duff, Leigh J Beglinger, Chiachi Wang, Justin J F O'Rourke, Julie C Stout, David J Moser. Neuropsychology 2010
62
22

Psychiatric disorders in preclinical Huntington's disease.
Camille L Julien, Jennifer C Thompson, Sue Wild, Pamela Yardumian, Julie S Snowden, Gwen Turner, David Craufurd. J Neurol Neurosurg Psychiatry 2007
154
14

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Sarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, Alexandra Durr, Blair Leavitt, Gail Owen, Rebecca Jones, Hans Johnson, David Craufurd, Stephen L Hicks,[...]. Lancet Neurol 2012
362
14

Huntington's disease: a clinical review.
Raymund A C Roos. Orphanet J Rare Dis 2010
441
14

Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.
Jurgen Lemiere, Marleen Decruyenaere, Gery Evers-Kiebooms, Erik Vandenbussche, Rene Dom. J Neurol 2004
174
13

Striatal and white matter predictors of estimated diagnosis for Huntington disease.
Jane S Paulsen, Peggy C Nopoulos, Elizabeth Aylward, Christopher A Ross, Hans Johnson, Vincent A Magnotta, Andrew Juhl, Ronald K Pierson, James Mills, Douglas Langbehn,[...]. Brain Res Bull 2010
170
13

Challenges assessing clinical endpoints in early Huntington disease.
Jane S Paulsen, Chiachi Wang, Kevin Duff, Roger Barker, Martha Nance, Leigh Beglinger, David Moser, Janet K Williams, Sheila Simpson, Douglas Langbehn,[...]. Mov Disord 2010
57
22

Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.
Jane S Paulsen, Jeffrey D Long, Hans J Johnson, Elizabeth H Aylward, Christopher A Ross, Janet K Williams, Martha A Nance, Cheryl J Erwin, Holly J Westervelt, Deborah L Harrington,[...]. Front Aging Neurosci 2014
138
13

Verbal episodic memory declines prior to diagnosis in Huntington's disease.
Andrea C Solomon, Julie C Stout, Shannon A Johnson, Douglas R Langbehn, Elizabeth H Aylward, Jason Brandt, Christopher A Ross, Leigh Beglinger, Michael R Hayden, Karl Kieburtz,[...]. Neuropsychologia 2007
93
12

Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease.
Shannon A Johnson, Julie C Stout, Andrea C Solomon, Douglas R Langbehn, Elizabeth H Aylward, Christina B Cruce, Christopher A Ross, Martha Nance, Elise Kayson, Elaine Julian-Baros,[...]. Brain 2007
136
12

Huntington disease: clinical care and evaluation.
I Shoulson, S Fahn. Neurology 1979
567
12

Rate of functional decline in Huntington's disease. Huntington Study Group.
K Marder, H Zhao, R H Myers, M Cudkowicz, E Kayson, K Kieburtz, C Orme, J Paulsen, J B Penney, E Siemers,[...]. Neurology 2000
261
12

Behavioral changes in Huntington Disease.
D Craufurd, J C Thompson, J S Snowden. Neuropsychiatry Neuropsychol Behav Neurol 2001
282
12

Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
Guerry M Peavy, Mark W Jacobson, Jody L Goldstein, Joanne M Hamilton, Amy Kane, Anthony C Gamst, Stephanie L Lessig, J C Lee, Jody Corey-Bloom. Mov Disord 2010
67
17

fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease.
Jane S Paulsen, Janice L Zimbelman, Sean C Hinton, Douglas R Langbehn, Catherine L Leveroni, Michelle L Benjamin, Norman C Reynolds, Stephen M Rao. AJNR Am J Neuroradiol 2004
171
11

Longitudinal change in regional brain volumes in prodromal Huntington disease.
Elizabeth H Aylward, Peggy C Nopoulos, Christopher A Ross, Douglas R Langbehn, Ronald K Pierson, James A Mills, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Jane S Paulsen. J Neurol Neurosurg Psychiatry 2011
175
11

Cerebral cortex structure in prodromal Huntington disease.
Peggy C Nopoulos, Elizabeth H Aylward, Christopher A Ross, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Ronald K Pierson, James Mills, Douglas R Langbehn, Jane S Paulsen. Neurobiol Dis 2010
97
11

"Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness.
Kevin Duff, Jane S Paulsen, Leigh J Beglinger, Douglas R Langbehn, Chiachi Wang, Julie C Stout, Christopher A Ross, Elizabeth Aylward, Noelle E Carlozzi, Sarah Queller. J Neuropsychiatry Clin Neurosci 2010
130
11

The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis.
Tamara Pringsheim, Katie Wiltshire, Lundy Day, Jonathan Dykeman, Thomas Steeves, Nathalie Jette. Mov Disord 2012
286
11

Regional cortical thinning in preclinical Huntington disease and its relationship to cognition.
H D Rosas, N D Hevelone, A K Zaleta, D N Greve, D H Salat, B Fischl. Neurology 2005
232
10

Psychopathology in verified Huntington's disease gene carriers.
E van Duijn, E M Kingma, R C van der Mast. J Neuropsychiatry Clin Neurosci 2007
183
10

Tracking motor impairments in the progression of Huntington's disease.
Jeffery D Long, Jane S Paulsen, Karen Marder, Ying Zhang, Ji-In Kim, James A Mills. Mov Disord 2014
38
26

Huntington's disease.
Francis O Walker. Lancet 2007
9

Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI.
Robert Christian Wolf, Nenad Vasic, Carlos Sch√∂nfeldt-Lecuona, G Bernhard Landwehrmeyer, Daniel Ecker. Brain 2007
108
9

fMRI detection of early neural dysfunction in preclinical Huntington's disease.
Janice L Zimbelman, Jane S Paulsen, Ania Mikos, Norman C Reynolds, Raymond G Hoffmann, Stephen M Rao. J Int Neuropsychol Soc 2007
83
10

Tapping linked to function and structure in premanifest and symptomatic Huntington disease.
N Bechtel, R I Scahill, H D Rosas, T Acharya, S J A van den Bogaard, C Jauffret, M J Say, A Sturrock, H Johnson, C E Onorato,[...]. Neurology 2010
96
9


Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
554
9

Early cognitive deficits in Swedish gene carriers of Huntington's disease.
Tarja-Brita Robins Wahlin, Anders Lundin, Keith Dear. Neuropsychology 2007
38
21


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.